evidencegaps
Primary study · included by 1 review

Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial.

Huang 2022 · Huang Xiaotao, Liu Qiaodan, Zhong Guihua, et al. · Journal of experimental & clinical cancer research : CR · 2022

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Huang 2022 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.